Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
06/11/2023 07:03
Nov 6 (Reuters) - Neovacs SA ALNEV.PA :
* PRESENTED THE LATEST RESULTS ON ITS VACCINE CANDIDATES
TARGETING
ALLERGIES DURING TWO INTERNATIONAL MEETINGS
* WORK PRESENTED DEMONSTRATES SIGNIFICANT PROGRESS ON THE
COMPANY'S TWO PROGRAMS, THE IL-4 AND IL-13 PROJECT AND ANTI IGE
PROJECT, FOR THE TREATMENT OF ALLERGIES
Source text for Eikon: ID:nACT82592
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants